Keywords: Boehringer Ingelheim, 2009 results
Boehringer Ingelheim again grows faster than pharma market, with 2009 net sales up nearly 10%
Article | 22 April 2010
Germany’s largest independent drug major, Boehringer Ingelheim, continued to grow in 2009, increasing its net sales by 9.7% to 12.7 billion ($17.16 billion). ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
